52090-68-3Relevant articles and documents
Isobenzazole-1-ketone compound having anti-inflammatory activity
-
Paragraph 0025; 0026; 0027, (2018/04/03)
The invention discloses an isobenzazole-1-ketone compound having an anti-inflammatory activity, and provides a compound shown in the formula (I) or a pharmaceutically acceptable salt of the compound.The disclosed isobenzazole-1-ketone compound having the anti-inflammatory activity obviously strengthens the drug targeting, and achieves better treatment effects on the diseases like multiple myelomaand rheumatoid arthritis.
AN IMPROVED PROCESS FOR THE PREPARATION OF (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE
-
Page/Page column 15, (2015/06/25)
The present invention is related to an improved and efficient process for preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine which comprises: (a) N-acylation of 3-Amino-4-methyl pyridine; (b) Quarternization of 3-Acetylamino-4- methyl pyridine using benzyl halide; (c) Partial reduction of quarternized 3-Acetylamino- 4-methyl pyridine by Sodium borohydride in Methanol or water; (d) Hydrolysis of partially reduced product to 1-Benzyl-4-methylpiperidin-3-one in presence of acid; (e) Reductive animation of 1-Benzyl-4-methylpiperidin-3-one using Methanolic methylamine in presence of Titanium(IV) isopropoxide in Methanol; (f) Resolution of 1-Benzyl-4- methylpiperidin-3-yl)-methylamine using Ditoluoyl (L) tartaric acid to get (3R,4R)-(1- benzyl-4-methylpiperidin-3-yl)-methylamine. The invention is also related to novel intermediates.
HETEROCYCLIC MODULATORS OF TGR5 FOR TREATMENT OF DISEASE
-
Page/Page column 16-17, (2009/04/24)
The present invention relates to compounds useful as modulators of TGR5 and methods for the treatment or prevention of metabolic, cardiovascular, and inflammatory diseases.